Bayer AG
BAYN.SW
Get informed when a big investor buys or sells
+ FollowMarket Cap$982.42B
Close$
$23.35
49.6% downside
Current Fair Value
49.6% downsideOvervalued by 49.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $982.42 Billion |
|---|---|
| Enterprise Value | $1.02 Trillion |
| Dividend Yield | $0.10 (0.25%) |
| Earnings per Share | $-3.68 |
| Beta | 0.83 |
| Outstanding Shares | 982,420,000 |
Return
| Return on Equity | -6.14% |
|---|---|
| Return on Assets | -1.69% |
| Return on Invested Capital | 7.14% |
Valuation & Multiples
| P/E Ratio | -24.87 |
|---|---|
| PEG | 11.74 |
| Price to Sales | 0.97 |
| Price to Book Ratio | 1.54 |
| Enterprise Value to Revenue | 21.52 |
| Enterprise Value to EBIT | 190.13 |
| Enterprise Value to Net Income | -561 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 1.35 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.71
Average shareholder expectationRevenue Estimate
$9.90 B
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$0.40
Average shareholder expectationRevenue Estimate
$9.36 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bayer AG
87,830 employees
CEO: Werner Baumann Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Ani...